Voquezna Triple Pak Interactions
There are 783 drugs known to interact with Voquezna Triple Pak (amoxicillin/clarithromycin/vonoprazan), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 296 are major, 437 are moderate, and 50 are minor.
- View all 783 medications that may interact with Voquezna Triple Pak
- View Voquezna Triple Pak alcohol/food interactions (1)
- View Voquezna Triple Pak disease interactions (12)
Most frequently checked interactions
View interaction reports for Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan) and the medicines listed below.
- albuterol
- Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine)
- allopurinol
- aloe vera
- alpha-lipoic acid
- azelastine nasal
- baclofen
- Bayer Aspirin Regimen (aspirin)
- Benlysta (belimumab)
- biotin
- cefdinir
- Celebrex (celecoxib)
- colchicine
- cyanocobalamin
- doxycycline
- Emergen-C (multivitamin with minerals)
- Excedrin Migraine (acetaminophen / aspirin / caffeine)
- Eye Multivitamin (multivitamin with minerals)
- famotidine
- ferrous sulfate
- folic acid
- furosemide
- gentamicin ophthalmic
- guaifenesin
- Humira (adalimumab)
- hydroxychloroquine
- ibuprofen
- Imvexxy (estradiol topical)
- ipratropium nasal
- pantoprazole
Voquezna Triple Pak alcohol/food interactions
There is 1 alcohol/food interaction with Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan).
Voquezna Triple Pak disease interactions
There are 12 disease interactions with Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan) which include:
- colitis
- mononucleosis
- diabetes
- PKU
- renal dysfunction
- hepatotoxicity
- renal dysfunction
- myasthenia gravis
- QT prolongation
- hemodialysis
- bone fractures
- mineral metabolism
Report options
More about Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan)
- Voquezna Triple Pak consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: H. pylori eradication agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
